Learning from the successes and failures of early artificial intelligence (AI) adoption for drug discovery in Big BioPharma

Martin Braddock, Krzysztof Jeziorski

Open source

DOI
10.1080/17460441.2026.2624023
Published
2026-01-30
Container
Expert Opinion on Drug Discovery
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17460441.2026.2624023,
  title = {Learning from the successes and failures of early artificial intelligence (AI) adoption for drug discovery in Big BioPharma},
  author = {Martin Braddock and Krzysztof Jeziorski},
  year = {2026},
  journal = {Expert Opinion on Drug Discovery},
  doi = {10.1080/17460441.2026.2624023},
  url = {https://doi.org/10.1080/17460441.2026.2624023}
}

RIS

TY  - JOUR
TI  - Learning from the successes and failures of early artificial intelligence (AI) adoption for drug discovery in Big BioPharma
AU  - Martin Braddock
AU  - Krzysztof Jeziorski
PY  - 2026
JO  - Expert Opinion on Drug Discovery
DO  - 10.1080/17460441.2026.2624023
UR  - https://doi.org/10.1080/17460441.2026.2624023
ER  - 

APA

Braddock, M., & Jeziorski, K. (2026). Learning from the successes and failures of early artificial intelligence (AI) adoption for drug discovery in Big BioPharma. Expert Opinion on Drug Discovery. https://doi.org/10.1080/17460441.2026.2624023

Source records